CLINICAL_TRIALS
trial_result
· 2015-10-29
Clinical Trial Update: A Dose-Range Finding Study in Participants With Type 2 Diabetes (MK-3102-006) [Phase 2]
Summary
Phase 2 dose-range finding trial in type 2 diabetes completed; results posted in 2015.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Merck Sharp & Dohme LLC | Conditions: Type 2 Diabetes Mellitus | Phase 2 | Status: COMPLETED | Results posted: 2015-10-29